February 2015

Transgenomic Announces Pricing of Public Offering of Common StockMarketWatchOMAHA, Neb., Feb 27, 2015 (BUSINESS WIRE) — Transgenomic, Inc. TBIO, +1.84% today announced the pricing of an underwritten public offering of 3,573,899 shares of the company’s common stock and corresponding warrants to purchase 714,780 shares …Transgenomic Announces Commencement of Public Offering of Common StockPharmiWeb.com (press release) […]

Transgenomic Announces Commencement of Public Offering of Common StockRock Hill Herald (press release)OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO) today announced that it intends to offer shares of the company’s common stock and corresponding warrants to purchase shares of the company’s common stock in an underwritten public offering.INSERTING and REPLACING Transgenomic Announces Pricing of Public

CollabRx Announces Closing of Public Offering of Common StockVirtual-Strategy Magazine (press release)25, 2015 (GLOBE NEWSWIRE) — CollabRx, Inc. (Nasdaq:CLRX) today announced the closing of its previously announced underwritten public offering of 3,840,000 shares of its common stock and warrants to purchase up to an aggregate of 3,840,000 shares … and more …read more

CollabRx Announces Closing of Public Offering of Common StockNasdaqSAN FRANCISCO, Feb. 25, 2015 (GLOBE NEWSWIRE) — CollabRx, Inc. (Nasdaq:CLRX) today announced the closing of its previously announced underwritten public offering of 3,840,000 shares of its common stock and warrants to purchase up to an … and more …read more

CollabRx Announces Closing of Public Offering of Common StockGlobeNewswire (press release)SAN FRANCISCO, Feb. 25, 2015 (GLOBE NEWSWIRE) — CollabRx, Inc. (Nasdaq:CLRX) today announced the closing of its previously announced underwritten public offering of 3,840,000 shares of its common stock and warrants to purchase up to an … and more …read more